Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ACOR Acorda Therapeutics > Detailed Quotes

ACOR Acorda Therapeutics

0.277
-0.014-4.81%
Close 09/29 16:00 ET
0.280
+0.003+1.19%
Post Mkt Price 09/29 17:47 ET
High
0.297
Open
0.261
Turnover
33.72K
Low
0.261
Pre Close
0.291
Volume
121.78K
Market Cap
6.73M
P/E(TTM)
Loss
52wk High
4.900
Shares
24.34M
P/E(Static)
Loss
52wk Low
0.261
Float Cap
5.93M
Bid/Ask %
20.00%
Historical High
272.700
Shs Float
21.43M
Volume Ratio
0.33
Historical Low
0.261
Dividend TTM
--
Div Yield TTM
--
P/B
0.08
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.57%
Amplitude
12.47%
Avg Price
0.276
Lot Size
1
Float Cap
5.93M
Bid/Ask %
20.00%
Historical High
272.700
Shs Float
21.43M
Volume Ratio
0.33
Historical Low
0.261
Dividend TTM
--
P/B
0.08
Dividend LFY
--
Turnover Ratio
0.57%
Amplitude
12.47%
Avg Price
0.276
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.
CEO: Dr. Ron Cohen, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...